Susan Wyrick
Patrimonio netto: 684 724 $ in data 30/06/2026
Patrimonio netto: 684 724 $ in data 30/06/2026
Ms. Susan D.
Wyrick, CPA, is a Senior Vice President-Finance & Accounting at Sana Biotechnology, Inc. Ms. Wyrick was previously employed as a Vice President & Controller by Juno Therapeutics, Inc. and a Chief Accounting Officer & Vice President-Finance by OncoGenex Pharmaceuticals, Inc. She received her undergraduate degree from the University of Washington.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/03/2026 | 196.196 ( 0,08% ) | 684 724 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 04/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/10/2018 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Auditor | 11/06/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale